CPT 88361Laboratory

Tumor immunohistochem/comput

CPT code 88361 covers computerized analysis of tumor tissue using special staining techniques (immunohistochemistry) to identify specific proteins or markers that help diagnose cancer types and guide treatment decisions.

Showing rates for

National Average

Base Medicare rate

$112.24

This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.

RVU breakdown

Work RVU

0.95

PE RVU (NF)

2.5

MP RVU

0.02

Total RVU

3.47

Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High

NCCI bundling edits

Loading bundling edits…

Billing tips

Document the specific computer-assisted quantification system used (FDA clearance number, software version, platform name) in the pathology report
Impact: Reduces denial risk by 40-50% when computer analysis is clearly distinguished from manual interpretation
Bill 88361 per single antibody stain with computer analysis, not per specimen; multiple biomarkers require multiple units with appropriate documentation
Impact: Correct unit reporting can increase legitimate reimbursement by 2-4x when multiple markers are quantified
Link to specific cancer diagnosis codes (C50.-, C34.-, C61, etc.) and include relevant biomarker information in claim documentation
Impact: Improves first-pass approval rate by 30-35% versus generic or unspecified neoplasm codes
Ensure computer analysis provides quantitative data (percentages, H-scores, intensity measurements) distinct from routine manual microscopic interpretation
Impact: Differentiates from basic 88342 immunohistochemistry codes which reimburse at lower rates ($35-45 less per stain)
Do not bill 88361 for every immunostain; reserve for cases where computer quantification is clinically necessary and actually performed
Impact: Prevents upcoding audits that can result in 3-year lookback reviews and potential recoupment of $50,000+
Maintain validation records demonstrating your computer analysis system meets CAP and ASCO/CAP guideline requirements for specific biomarkers
Impact: Essential for audit defense; lack of validation documentation is primary reason for 100% denial in RAC audits

Live Field Datano reports yet

Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.

Working with CPT 88361?

Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.

Help build the field knowledge

MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.

Related actions

Frequently asked questions

What is the Medicare reimbursement rate for CPT 88361 in 2025?

The 2025 Medicare national average payment for CPT 88361 is $112.24 for both facility and non-facility settings. This rate is based on 3.47 total RVUs (0.95 work RVU, 2.5 practice expense RVU, 0.02 malpractice RVU) multiplied by the 2025 conversion factor of 32.3465.

How does CPT 88361 differ from 88342 for immunohistochemistry billing?

CPT 88361 specifically requires computer-assisted quantitative analysis of immunohistochemical stains, providing objective measurements like percentages or scores. CPT 88342 covers manual interpretation of immunostains without computer quantification. Code 88361 reimburses approximately $75-80 more than 88342 but requires documentation of actual computer analysis, not just digital image viewing.

Can I bill multiple units of 88361 for the same specimen?

Yes, you can bill multiple units of 88361 when multiple different antibodies are quantified using computer-assisted analysis on the same or different specimens. Each unit represents one antibody stain with computer quantification. Documentation must clearly show separate computer analysis for each biomarker, and medical necessity for the complete panel must be established.

What documentation is required to support billing CPT 88361?

Required documentation includes: identification of the specific computer analysis system used, the antibody/biomarker quantified, quantitative results generated by the computer (percentages, H-scores, cell counts), pathologist interpretation of computer-generated data, clinical indication for testing, and evidence the computer analysis was actually performed. Generic statements about computer assistance are insufficient.

Does CPT 88361 include both professional and technical components?

Yes, CPT 88361 is a global code including both technical (computer analysis performance) and professional (interpretation) components. You can split billing using modifier 26 for professional component only or TC for technical component only when services are performed at different locations. The facility and non-facility rates are identical at $112.24 in 2025.

What are the most common reasons for denial of CPT 88361 claims?

The most common denials occur when: (1) pathology reports lack quantitative computer-generated data, (2) medical necessity for computer quantification versus manual interpretation is not established, (3) claims are bundled with routine immunohistochemistry codes, and (4) multiple units are billed without adequate documentation of separate biomarker analysis. Maintaining validation records and detailed quantitative reporting prevents most denials.

Which computer-assisted systems qualify for billing CPT 88361?

Qualifying systems must provide objective, automated quantification of immunohistochemical staining, not merely digital image viewing. FDA-cleared systems (like Ventana Image Analysis, Aperio algorithms, or Visiopharm) are preferred. Laboratory-developed systems require validation studies demonstrating accuracy and reproducibility. Simply viewing slides on a computer monitor or using basic photography does not constitute computer-assisted analysis for billing purposes.